QuiVad
My list

Home / Sweden / Hansa Biopharma AB

Hansa Biopharma AB

Short position disclosed on September 21, 2026.

Follow

Evolution of the disclosed total

0%2%4%6%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
Over the whole history, the total peaked at 4.82% on March 10, 2025. The shaded band matches the twelve months of the first chart.

January 15, 2019 today

Open positions

The funds disclosing a short position that is still open.
FundTwelve months% of capitalOver the yearSince
ActusRayPartners Limited0.90%+0.30 ptAugust 28, 2026
GSA Capital Partners LLP0.60%+0.06 ptSeptember 9, 2026
Worldquant LLC0.50%-0.08 ptSeptember 21, 2026

In the United States HNSBF (OTC): 62,228 shares sold short on August 31, 2026. FINRA names no fund.

On the other side: the funds that hold Hansa Biopharma AB Titelia

Follow by RSS

Get the moves on Hansa Biopharma AB by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

432 disclosures on record for this share.
DateFund% of capitalEnd of publication
December 19, 2022Arrowstreet Capital Limited Partnership0.58%
September 21, 2022Arrowstreet Capital Limited Partnership0.61%
September 15, 2022Millennium International Management LP0.87%
September 13, 2022Millennium International Management LP0.71%
September 12, 2022Millennium International Management LP0.63%
September 8, 2022Millennium International Management LP0.50%
September 7, 2022Arrowstreet Capital Limited Partnership0.51%
August 18, 2022Citadel Advisors LLC0.53%
July 20, 2022PDT Partners LLC0.52%
June 28, 2022Arrowstreet Capital Limited Partnership0.56%
June 8, 2022Arrowstreet Capital Limited Partnership0.68%
May 31, 2022Millennium International Management LP0.00%
May 27, 2022Millennium International Management LP0.60%
May 25, 2022Millennium International Management LP0.53%
May 3, 2022Marshall Wace LLP0.00%
April 27, 2022Marshall Wace LLP0.50%
April 11, 2022Marshall Wace LLP0.00%
April 6, 2022Arrowstreet Capital Limited Partnership0.77%
April 6, 2022Worldquant LLC0.00%
April 5, 2022Marshall Wace LLP0.57%
April 4, 2022Worldquant LLC0.57%
March 30, 2022Marshall Wace LLP0.67%
March 23, 2022Worldquant LLC0.69%
March 22, 2022Marshall Wace LLP0.78%
March 22, 2022Systematica Investments Limited0.00%
March 9, 2022Marshall Wace LLP0.89%
March 9, 2022Worldquant LLC0.70%
March 9, 2022Systematica Investments Limited0.59%
March 7, 2022Worldquant LLC0.63%
February 28, 2022Marshall Wace LLP0.90%
February 25, 2022Worldquant LLC0.51%
February 24, 2022Worldquant LLC0.00%
February 22, 2022Marshall Wace LLP0.89%
February 11, 2022Systematica Investments Limited0.60%
February 7, 2022Worldquant LLC0.51%
January 20, 2022Marshall Wace LLP0.99%
January 18, 2022Systematica Investments Limited0.50%
January 14, 2022Marshall Wace LLP1.06%
January 7, 2022Marshall Wace LLP1.16%
January 4, 2022Marshall Wace LLP1.22%
December 29, 2021Marshall Wace LLP1.13%
December 23, 2021Marshall Wace LLP1.00%
November 26, 2021Marshall Wace LLP0.92%
November 18, 2021Marshall Wace LLP0.82%
November 16, 2021Worldquant LLC0.00%
November 10, 2021Marshall Wace LLP0.79%
November 9, 2021Worldquant LLC0.56%
November 4, 2021Worldquant LLC0.69%
November 1, 2021Marshall Wace LLP0.89%
October 21, 2021Capital Fund Management SA0.00%

Download 432 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in Sweden

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Hansa Biopharma AB, source Finansinspektionen, data as at September 21, 2026, https://www.quivad.com/action/hansa-biopharma-ab?page=4